126 related articles for article (PubMed ID: 23387202)
1. [Association of CD44 polymorphisms with genetic susceptibilities and clinico-pathologic characteristics in breast cancer].
Zhou X; Wu CY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):807-11. PubMed ID: 23387202
[TBL] [Abstract][Full Text] [Related]
2. Association of p73 G4C14-A4T14 polymorphisms with genetic susceptibilities to breast cancer: a case-control study.
Zhou X; Wu C
Med Oncol; 2012 Dec; 29(5):3216-21. PubMed ID: 22535334
[TBL] [Abstract][Full Text] [Related]
3. Association of Single-Nucleotide Polymorphisms of CD44 Gene with Susceptibility to Breast Cancer in Chinese Women.
Lin X; You X; Cao X; Pan S
Med Sci Monit; 2018 May; 24():3077-3083. PubMed ID: 29748526
[TBL] [Abstract][Full Text] [Related]
4. [Association of single nucleotide polymorphisms in PAI-1 with breast cancer susceptibility and prognosis].
Chen YL; Jia YM; Xie YT; Li Y; Fang WG; Tian XX
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):533-9. PubMed ID: 27510778
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
6. [Association between CD24 polymorphism and genetic susceptibility to breast cancer: a case-control study].
Zhou X; Cao Y; Luo J; Zeng X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 38(11):1122-9. PubMed ID: 24316932
[TBL] [Abstract][Full Text] [Related]
7. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
[TBL] [Abstract][Full Text] [Related]
8. Gene Combination of CD44 rs187116, CD133 rs2240688, NF-κB1 rs28362491 and GSTM1 Deletion as a Potential Biomarker in Risk Prediction of Breast Cancer in Lower Northern Thailand.
Sapcharoen K; Sanguansermsri P; Yasothornsrikul S; Muisuk K; Srikummool M
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2493-2502. PubMed ID: 31450925
[TBL] [Abstract][Full Text] [Related]
9. Genetic Polymorphism in FSCN1 rs3801004 C/G and CD44 rs353639 A/C, as Prognostic Factor in Egyptian Breast Cancer Patients.
Ibrahim NE; Raafat Hamed RM; Refaat A; Mosaad YO; Mekawy DM
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3517-3523. PubMed ID: 37898858
[TBL] [Abstract][Full Text] [Related]
10. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province.
Fu Z; Jiao M; Zhang M; Xu F; Yuan W; Pang D; Li D
Breast Cancer Res Treat; 2011 May; 127(1):265-71. PubMed ID: 20953905
[TBL] [Abstract][Full Text] [Related]
11. TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
Chen Y; Shi C; Guo Q
World J Surg Oncol; 2016 Feb; 14(1):50. PubMed ID: 26911390
[TBL] [Abstract][Full Text] [Related]
12. CD44 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.
Chou YE; Hsieh MJ; Hsin CH; Chiang WL; Lai YC; Lee YH; Huang SC; Yang SF; Lin CW
PLoS One; 2014; 9(4):e93692. PubMed ID: 24699672
[TBL] [Abstract][Full Text] [Related]
13. CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.
Jiang L; Deng J; Zhu X; Zheng J; You Y; Li N; Wu H; Lu J; Zhou Y
Breast Cancer Res; 2012 Jul; 14(4):R105. PubMed ID: 22788972
[TBL] [Abstract][Full Text] [Related]
14. Associations of polymorphisms in microRNAs with female breast cancer risk in Chinese population.
He B; Pan Y; Xu Y; Deng Q; Sun H; Gao T; Wang S
Tumour Biol; 2015 Jun; 36(6):4575-82. PubMed ID: 25613069
[TBL] [Abstract][Full Text] [Related]
15. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
[TBL] [Abstract][Full Text] [Related]
16. CD44 gene polymorphisms in breast cancer risk and prognosis: a study in North Indian population.
Tulsyan S; Agarwal G; Lal P; Agrawal S; Mittal RD; Mittal B
PLoS One; 2013; 8(8):e71073. PubMed ID: 23940692
[TBL] [Abstract][Full Text] [Related]
17. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
Wang ML; Xu YX; Qian J; Wang FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
[TBL] [Abstract][Full Text] [Related]
18. CD24 polymorphisms cannot predict pathologic complete response to anthracycline- and taxane-based neoadjuvant chemotherapy in breast cancer.
Zhou X
Clin Breast Cancer; 2014 Apr; 14(2):e33-40. PubMed ID: 24393851
[TBL] [Abstract][Full Text] [Related]
19. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
20. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
